Antimicrobial Peptides

Antimicrobial Polymers

Volumn , Issue , 2011, Pages 195-225

  Marcos, Jose F ^a   Manzanares, Paloma ^b  

^a CSIC   (Spain)

^b INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

AMP encapsulation by liposomes; AMPs, as novel antimicrobials; Nanostructure forming AMPs

Indexed keywords

EID: 84886709888     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118150887.ch8     Document Type: Chapter

References (198)

1. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature, 415, 389-395.
2. Hancock, R. E. W., Sahl, H. G. (2006). Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology, 24, 1551-1557.
3. Peschel, A., Sahl, H. G. (2006). The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nature Reviews Microbiology, 4, 529-536.
4. Marcos, J. F., Beachy, R. N., Houghten, R. A., Blondelle, S. E., Pérez-Payá, E. (1995). Inhibition of a plant virus infection by analogs of melittin. Proceedings of the National Academy of Sciences of the USA, 92, 12466-12469.
5. Wachinger, M., Kleinschmidt, A., Winder, D., Von Pechmann, N., Ludvigsen, A., Neumann, M., Holle, R., Salmons, B., Erfle, V., Brack-Werner, R. (1998). Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. Journal of General Virology, 79, 731-740.
6. Edward, R., Jr., McDougall, B., Tran, D., Selsted, M. E. (1998). Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. Journal of Leukocyte Biology, 63, 94-100.
7. Klotman, M. E., Chang, T. L. (2006). Defensins in innate antiviral immunity. Nature Reviews Immunology, 6, 447-456.
8. Lai, Y., Gallo, R. L. (2009). AMPed up immunity: How antimicrobial peptides have multiple roles in immune defense. Trends in Immunology, 30, 131-141.
9. Hoskin, D. W., Ramamoorthy, A. (2008). Studies on anticancer activities of antimicrobial peptides. Biochimica et Biophysica Acta-Biomembranes, 1778, 357-375.
10. Henriques, S. T.,Melo, M.N.,Castanho,M.A.R.B. (2006). Cell-penetrating peptides and antimicrobial peptides: How different are they? Biochemical Journal, 399, 1-7.
11. Montesinos, E. (2007). Antimicrobial peptides and plant disease control. FEMS Microbiology Letters, 270, 1-11.
12. Marcos, J. F., Muñoz, A., Pérez-Payá, E., Misra, S., Lopez-García, B. (2008). Identification and rational design of novel antimicrobial peptides for plant protection. Annual Review of Phytopathology, 46, 273-301.
13. Rydlo, T., Miltz, J., Mor, A. (2006). Eukaryotic antimicrobial peptides: Promises and premises in food safety. Journal of Food Science, 71, 125-135.
14. Cotter, P. D., Hill, C., Ross, R. P. (2005). Bacteriocins: Developing innate immunity for food. Nature Reviews Microbiology, 3, 777-788.
15. Wang,G., Li,X.,Wang,Z. (2009).APD2:The updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Research, 37, D933-D937.
16. Fjell, C. D., Hancock, R. E. W., Cherkasov, A. (2007). AMPer: A database and an automated discovery tool for antimicrobial peptides. Bioinformatics, 23, 1148-1155.
17. Giuliani, A., Pirri, G., Nicoletto, S. (2007). Antimicrobial peptides: An overview of a promising class of therapeutics. Central European Journal of Biology, 2, 1-33.
18. Papagianni, M. (2003). Ribosomally synthesized peptides with antimicrobial properties: Biosynthesis, structure, function, and applications. Biotechnology Advances, 21, 465-499.
19. Romeo, D., Skerlavaj, B., Bolognesi, M., Gennaro, R. (1988). Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. Journal of Biological Chemistry, 263, 9573-9575.
20. Monk, B. C., Niimi, K., Lin, S., Knight, A., Kardos, T. B., Cannon, R. D., Parshot, R., King, A., Lun, D., Harding, D. R. K. (2005). Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrobial Agents and Chemotherapy, 49, 57-70.
21. Park, C. B., Kim, M. S., Kim, S. C. (1996). Novel antimicrobial peptide from Bufo bufo gargarizans. Biochemical and Biophysical Research Communications, 218, 408-413.
22. Oh, H., Hedberg, M., Wade, D., Edlund, C. (2000). Activities of synthetic hybrid peptides against anaerobic bacteria: Aspects of methodology and stability. Antimicrobial Agents and Chemotherapy, 44, 68-72.
23. Holak, T. A., Engströ m,â., Kraulis, P. J., Lindeberg, G., Bennich, H., Jones, T. A., Gronenborn, A. M., Clore, G. M. (1988). The solution conformation of the antibacterial peptide cecropin A: A nuclear magnetic resonance and dynamical simulated annealing study. Biochemistry, 27, 7620-7629.
24. De Lucca, A. J., Bland, J. M., Grimm, C., Jacks, T. J., Cary, J. W., Jaynes, J. M., Cleveland, T. E., Walsh, T. J. (1998). Fungicidal properties, sterol binding, and proteolytic resistance of the synthetic peptide D4E1. Canadian Journal of Botany, 44, 514-520.
25. Steven, M. D., Hotchkiss, J. H. (2008). Covalent immobilization of an antimicrobial peptide on poly(ethylene) film. Journal of Applied Polymer Science, 110, 2665-2670.
26. Cherkasov, A., Hilpert, K., Jenssen, H., Fjell, C. D., Waldbrook, M., Mullaly, S. C., Volkmer, R., Hancock, R. E. W. (2009). Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibioticresistant superbugs. ACS Chemical Biology, 4, 65-74.
27. Xu, T., Levitz, S. M., Diamond, R. D., Oppenheim, F. G. (1991). Anticandidal activity of major human salivary histatins. Infection and Immunity, 59, 2549-2554.
28. Rozek, A., Friedrich, C. L., Hancock, R. E. W. (2000). Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry, 39, 15765-15774.
29. Nguyen, L. T., Schibli, D. J., Vogel, H. J. (2005). Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. Journal of Peptide Science, 11, 379-389.
30. Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., Salcedo, R. (1996). The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. European Journal of Biochemistry, 238, 325-332.
31. Gesell, J., Zasloff, M., Opella, S. J. (1997). Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an a-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. Journal of Biomolecular NMR, 9, 127-135.
32. Raghuraman, H., Chattopadhyay, A. (2007). Melittin: A membrane-active peptide with diverse functions. Bioscience Reports, 27, 189-223.
33. DeGray, G., Rajasekaran, K., Smith, F., Sanford, J., Daniell, H. (2001). Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi. Plant Physiology, 127, 852-862.
34. López-García, B., Pérez-Payá, E., Marcos, J. F. (2002). Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library. Applied and Environmental Microbiology, 68, 2453-2460.
35. Jung, H. J., Park, Y., Hahm, K. S., Lee, D. G. (2006). Biological activity of Tat (47-58) peptide on human pathogenic fungi. Biochemical and Biophysical Research Communications, 345, 222-228.
36. Moreland, J., Gramada, A., Buzko, O., Zhang, Q., Bourne, P. (2005). The Molecular Biology Toolkit (MBT): A modular platform for developing molecular visualization applications. BMC Bioinformatics, 6, 1472-2105.
37. Batta, G., Barna, T., Gáspári, Z., Sándor, S., Kövér, K. E., Binder, U., Sarg, B., Kaiserer, L., Chhillar, A. K., Eigentler, A., Leiter, E., Hegedús, N., Pócsi, I., Lindner, H., Marx, F. (2009). Functional aspects of the solution structure and dynamics of PAF-A highly-stable antifungal protein from Penicillium chrysogenum. FEBS Journal, 276, 2875-2890.
38. Haney, E. F., Hunter, H. N., Matsuzaki, K., Vogel, H. J. (2009). Solution NMR studies of amphibian antimicrobial peptides: Linking structure to function? Biochimica et Biophysica Acta-Biomembranes, 1788, 1639-1655.
39. Zasloff, M., Martin, B., Chen, H. C. (1988). Antimicrobial activity of synthetic magainin peptides and several analogs. Proceedings of the National Academy of Sciences of the USA, 85, 910-913.
40. Boman, H. G., Hultmark, D. (1987). Cell-free immunity in insects. Annual Review of Microbiology, 41, 103-126.
41. Hultmark, D., Steiner, H., Rasmuson, T., Boman, H. G. (1980). Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia.European Journal ofBiochemistry, 106, 7-16.
42. Boman, H. G., Wade, D., Boman, I. A., Wahlin, B., Merrifield, R. B. (1989). Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Letters, 259, 103-106.
43. Wade, D., Andreu, D., Mitchell, S. A., Silveira, A. M., Boman, A., Boman, H. G., Merrifield, R. B. (1992). Antibacterial peptides designed as analogs or hybrids of cecropins and melittin. International Journal of Peptide and Protein Research, 40, 429-436.
44. Sato, H., Felix, J. B. (2006). Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic a-helical antimicrobial peptides. Biochimica et Biophysica Acta-Biomembranes, 1758, 1245-1256.
45. Saugar, J. M., Rodríguez-Hernández, M. J., de la Torre, B. G., Pachón-Ibañez, M. E., Fernández-Reyes, M., Andreu, D., Pachón, J., Rivas, L. (2006). Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: Molecular basis for the differential mechanisms of action. Antimicrobial Agents and Chemotherapy, 50, 1251-1256.
46. Bals, R., Wang, X., Zasloff, M., Wilson, J. M. (1998). The peptide antibiotic LL-37/ hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proceedings of the National Academy of Sciences of the USA, 95, 9541-9546.
47. Durr, U. H. N., Sudheendra, U. S., Ramamoorthy, A. (2006). LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochimica et Biophysica Acta-Biomembranes, 1758, 1408-1425.
48. Murakami, M., López-García, B., Braff, M., Dorschner, R. A., Gallo, R. L. (2004). Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. Journal of Immunology, 172, 3070-3077.
49. Selsted, M. E., Novotny, M. J., Morris, W. L., Tang, Y. Q., Smith, W., Cullor, J. S. (1992). Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. Journal of Biological Chemistry, 267, 4292-4295.
50. Falla, T. J., Karunaratne, D. N., Hancock, R. E. W. (1996). Mode of action of the antimicrobial peptide indolicidin. Journal of Biological Chemistry, 271, 19298-19303.
51. Schibli, D. J., Epand, R. F., Vogel, H. J., Epand, R. M. (2002). Tryptophan-rich antimicrobial peptides: Comparative properties and membrane interactions. Biochemistry and Cell Biology, 80, 667-677.
52. Ganz, T. (2003). Defensins: Antimicrobial peptides of innate immunity. Nature Reviews Immunology, 3, 710-720.
53. Carvalho, A., Gomes, V. M. (2009). Plant defensins-Prospects for the biological functions and biotechnological properties. Peptides, 30, 1007-1020.
54. Broekaert, W. F., Cammue, B. P. A., De Bolle, M. F., Thevissen, K., De Samblanx, G. W., Osborn, R. W. (1997). Antimicrobial peptides from plants. Critical Reviews in Plant Sciences, 16, 297-323.
55. Campos-Olivas, R., Bruix, M., Santoro, J., Lacadena, J., Martínez del Pozo, A., Gavilanes, J. G., Rico, M. (1995). NMR solution structure of the antifungal protein from Aspergillus giganteus: Evidence for cysteine pairing isomerism. Biochemistry, 34, 3009-3021.
56. Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sonksen, C. P., Ludvigsen, S., Raventos, D., Buskov, S., Christensen, B.,De Maria, L., Taboureau, O., Yaver, D., Elvig-Jorgensen, S. G., Sorensen, M. V., Christensen, B. E., Kjaerulff, S., Frimodt-Moller, N., Lehrer, R. I., Zasloff, M., Kristensen, H. H. (2005). Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature, 437, 975-980.
57. Schneider, T., Kruse, T., Wimmer, R., Wiedemann, I., Sass, V., Pag, U., Jansen, A., Nielsen, A. K., Mygind, P. H., Raventos, D. S.,Neve, S., Ravn, B., Bonvin, A. M. J. J., De Maria, L., Andersen, A. S., Gammelgaard, L. K., Sahl, H. G., Kristensen, H. H. (2010). Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science, 328, 1168-1172.
58. Gálvez, A., Abriouel, H., López, R. L., Omar, N. B. (2007). Bacteriocin-based strategies for food biopreservation. International Journal of Food Microbiology, 120, 51-70.
59. Bierbaum, G., Sahl, H.G. (2009). Lantibiotics: Mode of action, biosynthesis and bioengineering. Current Pharmaceutical Biotechnology, 10, 2-18.
60. Tiwari, B. K., Valdramidis, V. P., O'Donnell, C. P., Muthukumarappan, K., Bourke, P., Cullen, P. J. (2009). Application of natural antimicrobials for food preservation. Journal of Agricultural and Food Chemistry, 57, 5987-6000.
61. Finking, R., Marahiel, M. A. (2004). Biosynthesis of nonribosomal peptides. Annual Review of Microbiology, 58, 453-488.
62. Prenner, E. J., Lewis, R. N. A. H., Mc Elhaney, R. N. (1999). The interaction of the antimicrobial peptide gramicidin S with lipid bilayer model and biological membranes. Biochimica et Biophysica Acta-Biomembranes, 1462, 201-221.
63. Gifford, J. L., Hunter, H. N., Vogel, H. J. (2005). Lactoferricin: A lactoferrinderived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cellular and Molecular Life Sciences, 62, 2588-2598.
64. Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., Tomita,M. (1992). Identification of the bactericidal domain of lactoferrin. Biochimica et Biophysica Acta-Protein Structure and Molecular Enzymology, 1121, 130-136.
65. van der Kraan, M. I. A., Groenink, J., Nazmi, K., Veerman, E. C. I., Bolscher, J. G. M., Nieuw Amerongen, A. V. (2004). Lactoferrampin: A novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides, 25, 177-183.
66. Mine, Y., Ma, F. P., Lauriau, S. (2004). Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme. Journal of Agricultural and Food Chemistry, 52, 1088-1094.
67. Froidevaux, R., Krier, F., Nedjar-Arroume, N., Vercaigne-Marko, D., Kosciarz, E., Ruckebusch, C., Dhulster, P., Guillochon, D. (2001). Antibacterial activity of a pepsin-derived bovine hemoglobin fragment. FEBS Letters, 491, 159-163.
68. Blondelle, S. E., Lohner, K. (2000). Combinatorial libraries: A tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. Biopolymers, 55, 74-87.
69. Matsuzaki, K. (2009). Control of cell selectivity of antimicrobial peptides. Biochimica et Biophysica Acta-Biomembranes, 1788, 1687-1692.
70. Hallock, K. J., Lee, D. K., Ramamoorthy, A. (2003). MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophysical Journal, 84, 3052-3060.
71. Blondelle, S. E., Houghten, R. A. (1991). Hemolytic and antimicrobial activities of the 24 individual omission analogs of melittin. Biochemistry, 30, 4671-4678.
72. Friedrich, C. L., Rozek, A., Patrzykat, A., Hancock, R. E. W. (2001). Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. Journal of Biological Chemistry, 276, 24015-24022.
73. Farnaud, S., Spiller, C., Moriarty, L., Patel, A., Gant, V., Odell, E. W., Evans, R. (2004). Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. FEMS Microbiology Letters, 233, 193-199.
74. Strom, M. B., Erik Haug, B., Rekdal, O., Skar, M. L., Stensen, W., Svendsen, J. S. (2002). Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. Biochemistry and Cell Biology, 80, 65-74.
75. Andreu, D., Ubach, J., Boman, A., Wahlin, B., Wade, D., Merrifield, R. B., Boman, H. G. (1992). Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Letters, 296, 190-194.
76. Ferre, R., Badosa, E., Feliu, L., Planas, M., Montesinos, E., Bardají, E. (2006). Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides. Applied and Environmental Microbiology, 72, 3302-3308.
77. Chen, Y., Mant, C. T., Farmer, S.W., Hancock, R. E. W., Vasil,M. L., Hodges, R. S. (2005). Rational design of a-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. Journal of Biological Chemistry, 280, 12316-12329.
78. Zhang, L., Benz, R., Hancock, R. E. W. (1999). Influence of proline residues on the antibacterial and synergistic activities of a-helical peptides. Biochemistry, 38, 8102-8111.
79. Hwang, P. M., Vogel, H. J. (1998). Structure-function relationships of antimicrobial peptides. Biochemistry and Cell Biology, 76, 235-246.
80. Lejon, T., Stiberg, T., Strom, M. B., Svendsen, J. S. (2004). Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins. Journal of Peptide Science, 10, 329-335.
81. Frecer, V., Ho, B., Ding, J. L. (2004). De novo design of potent antimicrobial peptides. Antimicrobial Agents and Chemotherapy, 48, 3349-3357.
82. Houghten, R.A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T., Cuervo, J.H. (1991). Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature, 354, 84-86.
83. Blondelle, S. E., Pérez-Payá, E., Houghten, R. A. (1996). Synthetic combinatorial libraries: Novel discovery strategy for identification of antimicrobial agents. Antimicrobial Agents and Chemotherapy, 40, 1067-1071.
84. Hilpert, K., Volkmer-Engert, R., Walter, T., Hancock, R. E. W. (2005). Highthroughput generation of small antibacterial peptides with improved activity. Nature Biotechnology, 23, 1008-1012.
85. Wade, D., Boman, A., Wahlin, B., Drain, C. M., Andreu, D., Boman, H. G., Merrifield, R. B. (1990). All-D amino acid-containing channel-forming antibiotic peptides. Proceedings of the National Academy of Sciences of the USA, 87, 4761-4765.
86. Muñoz, A., López-García, B., Pérez-Payá, E., Marcos, J. F. (2007). Antimicrobial properties of derivatives of the cationic tryptophan-rich hexapeptide PAF26. Biochemical and Biophysical Research Communications, 354, 172-177.
87. Gonzalez, C. F., Provin, E. M., Zhu, L., Ebbole, D. J. (2002). Independent and synergistic activity of synthetic peptides against thiabendazole-resistant Fusarium sambucinum. Phytopathology, 92, 917-924.
88. Badosa, E., Ferre, R., Planas, M., Feliu, L., Besalu, E., Cabrefiga, J., Bardaji, E., Montesinos, E. (2007). A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Peptides, 28, 2276-2285.
89. Blondelle, S. E., Takahashi, E., Houghten, R. A., Pérez-Payá, E. (1996). Rapid identification of compounds with enhanced antimicrobial activity by using conformationally defined combinatorial libraries. Biochemical Journal, 313, 141-147.
90. Raventós, D., Taboureau, O., Mygind, P. H., Nielsen, J. D., Sonksen, C. P., Kristensen, H. H. (2005). Improving on nature's defenses: Optimization & high throughput screening of antimicrobial peptides. Combinatorial Chemistry & High Throughput Screening, 8, 219-233.
91. Soltani, S., Keymanesh, K., Sardari, S. (2007). In silico analysis of antifungal peptides: Determining the lead template sequence of potent antifungal peptides. Expert Opinion on Drug Discovery, 2, 837-847.
92. Fjell, C. D., Hancock, R. E. W., Jenssen, H. (2010). Computer-aided design of antimicrobial peptides. Current Pharmaceutical Analysis, 6, 66-75.
93. Oren, Z., Shai, Y. (2000). Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: Effect on structure, interaction with model membranes, and biological function. Biochemistry, 39, 6103-6114.
94. Fernandez-Lopez, S., Kim, H. S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A., Kraehenbuehl, K., Long, G., Weinberger, D. A., Wilcoxen, K. M., Ghadiri, M. R. (2001). Antibacterial agents based on the cyclic D,L-a-peptide architecture. Nature, 414, 329-329.
95. Makovitzki, A., Avrahami, D., Shai, Y. (2006). Ultrashort antibacterial and antifungal lipopeptides. Proceedings of the National Academy of Sciences of the USA, 103, 15997-16002.
96. Serrano, G. N., Zhanel, G. G., Schweizer, F. (2009). Antibacterial activity of ultrashort cationic lipo-b-peptides. Antimicrobial Agents and Chemotherapy, 53, 2215-2217.
97. Makovitzki, A., Baram, J., Shai, Y. (2008). Antimicrobial lipopolypeptides composed of palmitoyl di-and tricationic peptides: In vitro and in vivo activities, self-assembly to nanostructures, and a plausible mode of action. Biochemistry, 47, 10630-10636.
98. Bracci, L., Falciani, C., Lelli, B., Lozzi, L., Runci, Y., Pini, A., De Montis, M. G., Tagliamonte, A.,Neri, P. (2003). Synthetic peptides in the formof dendrimers become resistant to protease activity. Journal of Biological Chemistry, 278, 46590-46595.
99. Tam, J. P., Lu, Y. A., Yang, J. L. (2002). Antimicrobial dendrimeric peptides. European Journal of Biochemistry, 269, 923-932.
100. Rotem, S., Mor, A. (2009). Antimicrobial peptide mimics for improved therapeutic properties. Biochimica et Biophysica Acta-Biomembranes, 1788, 1582-1592.
101. Scott, R. W., De Grado, W. F., Tew, G. N. (2008). De novo designed synthetic mimics of antimicrobial peptides. Current Opinion in Biotechnology, 19, 620-627.
102. Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., Barron, A. E. (2008). Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proceedings of the National Academy of Sciences of the USA, 105, 2794-2799.
103. Oren, Z., Shai, Y. (1998). Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers, 47, 451-463.
104. Yeaman, M. R., Yount, N. Y. (2003). Mechanisms of antimicrobial peptide action and resistance. Pharmacological Reviews, 55, 27-55.
105. Brogden, K. A. (2005). Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nature Reviews Microbiology, 3, 238-250.
106. Jenssen, H., Hamill, P., Hancock, R. E. W. (2006). Peptide antimicrobial agents. Clinical Microbiology Reviews, 19, 491-511.
107. Hale, J. D., Hancock, R. E. W. (2007). Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Review of Anti-Infective Therapy, 5, 951-959.
108. Marcos, J. F., Gandía, M. (2009). Antimicrobial peptides: To membranes and beyond. Expert Opinion on Drug Discovery, 4, 659-671.
109. Breukink, E., Wiedemann, I., van Kraaij, C., Kuipers, O. P., Sahl, H. G., de Kruijff, B. (1999). Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science, 286, 2361-2364.
110. Thevissen, K., Warnecke, D. C., Francois, I. E. J. A., Leipelt, M., Heinz, E., Ott, C., Zahringer, U., Thomma, B. P. H. J., Ferkel, K. K. A., Cammue, B. P. A. (2004). Defensins from insects and plants interact with fungal glucosylceramides. Journal of Biological Chemistry, 279, 3900-3905.
111. Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R., Otvos, L., Jr. (2001). The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry, 40, 3016-3026.
112. Sun, J. N. N., Li, W. S., Jang, W. S., Nayyar, N., Sutton, M. D., Edgerton, M. (2008). Uptake of the antifungal cationic peptide Histatin 5 by Candida albicans Ssa2p requires binding to non-conventional sites within the ATPase domain. Molecular Microbiology, 70, 1246-1260.
113. Leiter, E., Szappanos, H., Oberparleiter, C., Kaiserer, L., Csernoch, L., Pusztahelyi, T., Emri, T., Posci, I., Salvenmoser, W., Marx, F. (2005). Antifungal protein PAF severely affects the integrity of the plasma membrane of Aspergillus nidulans and induces an apoptosis-like phenotype. Antimicrobial Agents and Chemotherapy, 49, 2445-2453.
114. Morton, C. O., dos Santos, S. C., Coote, P. (2007). An amphibian-derived, cationic, a-helical antimicrobial peptide kills yeast by caspase-independent but AIF-dependent programmed cell death. Molecular Microbiology, 65, 494-507.
115. Narasimhan, M. L., Damsz, B., Coca, M. A., Ibeas, J. I., Yun, D. J., Pardo, J. M., Hasegawa, P. M., Bressan, R. A. (2001). A plant defense response effector induces microbial apoptosis. Molecular Cell, 8, 921-930.
116. Kramer, N. E., Van Hijum, S. A. F. T., Knol, J., Kok, J., Kuipers, O. P. (2006). Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance. Antimicrobial Agents and Chemotherapy, 50, 1753-1761.
117. Li, M., Lai, Y. P., Villaruz, A. E., Cha, D. J., Sturdevant, D. E., Otto, M. (2007). Gram-positive three-component antimicrobial peptide-sensing system. Proceedings of the National Academy of Sciences of the USA, 104, 9469-9474.
118. Hong, R. W., Shchepetov, M., Weiser, J. N., Axelsen, P. H. (2003). Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide Cecropin A. Antimicrobial Agents and Chemotherapy, 47, 1-6.
119. Tomasinsig, L., Scocchi, M., Mettulio, R., Zanetti, M. (2004). Genome-wide transcriptional profiling of the Escherichia coli response to a proline-rich antimicrobial peptide. Antimicrobial Agents and Chemotherapy, 48, 3260-3267.
120. Vylkova, S., Jang, W. S., Li, W.S., Nayyar, N., Edgerton, M. (2007). Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase pathway. Eukaryotic Cell, 6, 1876-1888.
121. Lis, M., Fuss, J. R., Bobek, L. A. (2009). Exploring the mode of action of antimicrobial peptide MUC7 12-mer by fitness profiling of Saccharomyces cerevisiae genomewide mutant collection. Antimicrobial Agents and Chemotherapy, 53, 3762-3769.
122. Morton, C. O., Hayes, A., Wilson, M., Rash, B. M., Oliver, S. G., Coote, P. (2007). Global phenotype screening and transcript analysis outlines the inhibitory mode(s) of action of two amphibian-derived, a-helical, cationic peptides on Saccharomyces cerevisiae. Antimicrobial Agents and Chemotherapy, 51, 3948-3959.
123. López-García, B., Gandía, M., Muñoz, A., Carmona, L., Marcos, J. F. (2010). A genomic approach highlights common and diverse effects and determinants of susceptibility on the yeast Saccharomyces cerevisiae exposed to distinct antimicrobial peptides. BMC Microbiology, 10, 289-124.
124. Otvos, L., Jr. (2005). Antibacterial peptides and proteins with multiple cellular targets. Journal of Peptide Science, 11, 697-706
125. Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., Gotz, F. (1999). Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. Journal of Biological Chemistry, 274, 8405-8410.
126. Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., Miller, S. I. (1998). Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell, 95, 189-198.
127. Gamberi, T., Cavalieri, D., Magherini, F., Mangoni, L., De Filippo, C., Borro, M., Gentile, G., Simmaco, M., Modesti, A. (2007). An integrated analysis of the effects of Esculentin 1-21 on Saccharomyces cerevisiae. Biochimica et Biophysica Acta-Proteins and Proteomics, 1774, 688-700.
128. Rosenfeld, Y., Barra, D., Simmaco, M., Shai, Y., Mangoni, M. L. (2006). A synergism between temporins toward gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. Journal of Biological Chemistry, 281, 28565-28574.
129. van der Weerden, N. L., Hancock, R. E. W., Anderson, M. A. (2010). Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell walldependent process. Journal of Biological Chemistry, 285, 37513-37520.
130. Hsu, S. T. D., Breukink, E., Tischenko, E., Lutters, M. A. G., de Kruijff, B., Kaptein, R., Bonvin, A. M. J. J., van Nuland, N. A. J. (2004). The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nature Structural & Molecular Biology, 11, 963-967.
131. Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., Sahl, H. A. (2001). Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. Journal of Biological Chemistry, 276, 1772-1779.
132. Dielbandhoesing, S. K., Zhang, H., Caro, L. H., van der Vaart, J. M., Klis, F. M., Verrips, C. T., Brul, S. (1998). Specific cell wall proteins confer resistance to Nisin upon yeast cells. Applied and Environmental Microbiology, 64, 4047-4052.
133. Park, C. B., Yi, K. S., Matsuzaki, K., Kim, M. S., Kim, S. C. (2000). Structureactivity analysis of buforin II, a histone H2A-derived antimicrobial peptide: The proline hinge is responsible for the cell-penetrating ability of buforin II. Proceedings of the National Academy of Sciences of the USA, 97, 8245-8250.
134. Muñoz, A., López-García, B., Marcos, J. F. (2006). Studies on the mode of action of the antifungal hexapeptide PAF26. Antimicrobial Agents and Chemotherapy, 50, 3847-3855.
135. Palm, C., Netzerea, S., Hallbrink, M. (2006). Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides, 27, 1710-1716.
136. Park, C. B., Kim, H. S., Kim, S. C. (1998). Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochemical and Biophysical Research Communications, 244, 253-257.
137. Subbalakshmi, C., Sitaram, N. (1998). Mechanism of antimicrobial action of indolicidin. FEMS Microbiology Letters, 160, 91-96.
138. Castle, M., Nazarian, A., Yi, S. S., Tempst, P. (1999). Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets. Journal of Biological Chemistry, 274, 32555-32564.
139. Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S. L., Ganz, T., Selsted, M. E. (1989). Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. Journal of Clinical Investigation, 84, 553-561.
140. Boman, H. G., Agerberth, B., Boman, A. (1993). Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infection and Immunity, 61, 2978-2984.
141. Mochon, A. B., Liu, H. P. (2008). The antimicrobial peptide Histatin-5 causes a spatially restricted disruption on the Candida albicans surface, allowing rapid entry of the peptide into the cytoplasm. PLoS Pathogens, 4, e100 0190.
142. Lobo, D. S., Pereira, I. B., Fragel-Madeira, L., Medeiros, L. N., Cabral, L. M., Faria, J., Bellio, M., Campos, R. C., Linden, R., Kurtenbach, E. (2007). Antifungal Pisum sativum defensin 1 interacts with Neurospora crassa cyclin F related to the cell cycle. Biochemistry, 46, 987-996.
143. Chadha, P., Das, R. H. (2006). A pathogenesis related protein, AhPR10 from peanut: An insight of its mode of antifungal activity. Planta, 225, 213-222.
144. de Arauz, L. J., Jozala, A. F., Mazzola, P. G., Vessoni Penna, T. C. (2009). Nisin biotechnological production and application: A review. Trends in Food Science and Technology, 20, 146-154.
145. Alexander, D. C., Rock, J., He, X., Brian, P., Miao, V., Baltz, R. H. (2010). Development of a genetic system for combinatorial biosynthesis of lipopeptides in Streptomyces fradiae and heterologous expression of the A54145 biosynthesis gene cluster. Applied and Environmental Microbiology, 76, 6877-6887.
146. Coeffet-Le Gal, M. F., Thurston, L., Rich, P., Miao, V., Baltz, R. H. (2006). Complementation of daptomycin dptA and dptD deletion mutations in trans and production of hybrid lipopeptide antibiotics. Microbiology-SGM, 152, 2993-3001.
147. Chiocchini, C., Linne, U., Stachelhaus, T. (2006). In vivo biocombinatorial synthesis of lipopeptides by COM domain-mediated reprogramming of the surfactin biosynthetic complex. Chemistry and Biology, 13, 899-908.
148. Ingham, A. B., Moore, R. J. (2007). Recombinant production of antimicrobial peptides in heterologous microbial systems. Biotechnology and Applied Biochemistry, 047, 1-9.
149. Zhang, L., Falla, T., Wu, M., Fidai, S., Burian, J., Kay, W., Hancock, R. E. W. (1998). Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria. Biochemical and Biophysical Research Communications, 247, 674-680.
150. Zorko, M., Jerala, R. (2010). Production of recombinant antimicrobial peptides in bacteria. Methods in Molecular Biology, 618, 61-76.
151. Bommarius, B., Jenssen, H., Elliott, M., Kindrachuk, J., Pasupuleti, M., Gieren, H., Jaeger, K. E., Hancock, R. E. W., Kalman, D. (2010). Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides, 31, 1957-1965.
152. Vidovic, V., Prongidi-Fix, L., Bechinger, B., Werten, S. (2009). Production and isotope labeling of antimicrobial peptides in Escherichia coli by means of a novel fusion partner that enables high-yield insoluble expression and fast purification. Journal of Peptide Science, 15, 278-284.
153. Piers, K. L., Brown, M. H., Hancock, R. E. W. (1993). Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene, 134, 7-13.
154. Kim, H. K., Chun, D. S., Kim, J. S., Yun, C. H., Lee, J. H., Hong, S. K., Kang, D. K. (2006). Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli. Applied Microbiology and Biotechnology, 72, 330-338.
155. Lee, J. H., Minn, I., Park, C. B., Kim, S. C. (1998). Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli. Protein Expression and Purification, 12, 53-60.
156. Morin, K., Arcidiacono, S., Beckwitt, R., Mello, C. (2005). Recombinant expression of indolicidin concatamers in Escherichia coli. Applied Microbiology and Biotechnology, 70, 698-704.
157. Metlitskaia, L., Cabralda, J. E., Suleman, D., Kerry, C., Brinkman, J., Bartfeld, D., Guarna, M. M. (2004). Recombinant antimicrobial peptides efficiently produced using novel cloning and purification processes. Biotechnology and Applied Biochemistry, 39, 339-345.
158. Kim, S. J., Quan, R. S., Lee, S. J., Lee, H. K., Choi, J. K. (2009). Antibacterial activity of recombinant hCAP18/LL37 protein secreted from Pichia pastoris. Journal of Microbiology, 47, 358-362.
159. Katsikogianni, M., Missirlis, Y. F. (2004). Concise review of mechanisms of bacterial adhesion to biomaterials and of techniques used in estimating bacteriamaterial interactions. European Cells and Materials, 8, 37-57.
160. Costerton, J. W., Cheng, K. J., Geesey, G. G., Ladd, T. I., Nickel, J. C., Dasgupta, M., Marrie, T. J. (1987). Bacterial biofilms in nature and disease. Annual Review of Microbiology, 41, 435-464.
161. Donlan, R. M., Costerton, J. W. (2002). Biofilms: Survival mechanisms of clinically relevant microorganisms. Clinical Microbiology Reviews, 15, 167-193.
162. Humblot, V., Yala, J. F., Thebault, P., Boukerma, K., Héquet, A., Berjeaud, J.M., Pradier, C. M. (2009). The antibacterial activity of magainin I immobilized onto mixed thiols self-assembled monolayers. Biomaterials, 30, 3503-3512.
163. Vreuls, C., Zocchi, G., Thierry, B., Garitte, G., Griesser, S. S., Archambeau, C., Van de Weerdt, C. V., Martial, J., Griesser, H. (2010). Prevention of bacterial biofilms by covalent immobilization of peptides onto plasma polymer functionalized substrates. Journal of Materials Chemistry, 20, 8092-8098.
164. Etienne, O., Gasnier, C., Taddei, C., Voegel, J. C., Aunis, D., Schaaf, P., Metz-Boutigue, M. H., Bolcato-Bellemin, A. L., Egles, C. (2005). Antifungal coating by biofunctionalized polyelectrolyte multilayered films. Biomaterials, 26, 6704-6712.
165. Etienne, O., Picart, C., Taddei, C., Haikel, Y., Dimarcq, J. L., Schaaf, P., Voegel, J. C., Ogier, J. A., Egles, C. (2004). Multilayer polyelectrolyte films functionalized by insertion of defensin: A new approach to protection of implants from bacterial colonization. Antimicrobial Agents and Chemotherapy, 48, 3662-3669.
166. Guyomard, A. DéE., Jouenne, T., Malandain, J. J., Muller, G., Glinel, K. (2008). Incorporation of a hydrophobic antibacterial peptide into amphiphilic polyelectrolyte multilayers: A bioinspired approach to prepare biocidal thin coatings. Advanced Functional Materials, 18, 758-765.
167. Orivel, J., Redeker, V., Le Caer, J. P., Krier, F., Revol-Junelles, A. M., Longeon, A., Chaffotte, A., Dejean, A., Rossier, J. (2001). Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Journal of Biological Chemistry, 276, 17823-17829.
168. Shukla, A., Fleming, K. E., Chuang, H. F., Chau, T. M., Loose, C. R., Stephanopoulos, G. N., Hammond, P. T. (2010). Controlling the release of peptide antimicrobial agents from surfaces. Biomaterials, 31, 2348-2357.
169. Yoshinari, M., Kato, T., Matsuzaka, K., Hayakawa, T., Inoue, T., Oda, Y., Okuda, K., Shimono, M. (2006). Adsorption behavior of antimicrobial peptide histatin 5 on PMMA. Journal of Biomedical Materials Research, 77, 47-54.
170. De Prijck, K., De Smet, N., Rymarczyk-Machal, M., Van Driessche, G., Devreese, B., Coenye, T., Schacht, E., Nelis, H. J. (2010). Candida albicans biofilm formation on peptide functionalized polydimethylsiloxane. Biofouling, 26, 269-275.
171. Bai, L., Zhu, L., Min, S., Liu, L., Cai, Y., Yao, J. (2008). Surface modification and properties of Bombyx mori silk fibroin films by antimicrobial peptide. Applied Surface Science, 254, 2988-2995.
172. Izquierdo-Barba, I., Vallet-Regí, M., Kupferschmidt, N., Terasaki, O., Schmidtchen, A., Malmsten, M. (2009). Incorporation of antimicrobial compounds in mesoporous silica film monolith. Biomaterials, 30, 5729-5736.
173. Zampa, M. F., Araújo, I. M. S., Costa, V., Nery Costa, C. H., Santos, J. R., Jr., Zucolotto, V., Eiras, C., Leite, J. R. S. A. (2009). Leishmanicidal Activity and Immobilization of dermaseptin 01 antimicrobial peptides in ultrathin films for nanomedicine applications. Nanomedicine: Nanotechnology, Biology, and Medicine, 5, 352-358.
174. Bower, C. K., McGuire, J., Daeschel, M. A. (1995). Suppression of Listeria monocytogenes colonization following adsorption of nisin onto silica surfaces. Applied and Environmental Microbiology, 61, 992-997.
175. Siragusa, G. R., Cutter, C. N., Willett, J. L. (1999). Incorporation of bacteriocin in plastic retains activity and inhibits surface growth of bacteria on meat. Food Microbiology, 16, 229-235.
176. Scannell, A. G. M., Hill, C., Ross, R. P., Marx, S., Hartmeier, W., Arendt, E. K. (2000). Development of bioactive food packaging materials using immobilised bacteriocins Lacticin 3147 and Nisaplins. International Journal of Food Microbiology, 60, 241-249.
177. Neetoo, H., Ye, M., Chen, H. Q. (2007). Effectiveness and stability of plastic films coated with nisin for inhibition of Listeria monocytogenes. Journal of Food Protection, 70, 1267-1271.
178. Limjaroen, P., Ryser, E., Lockhart, H., Harte, B. (2003). Development of a food packaging coating material with antimicrobial properties. Journal of Plastic Film & Sheeting, 19, 95-109.
179. Miltz, J., Rsydlo, T., Mor, A., Polyakov, V. (2006). Potency evaluation of a dermaseptin S4 derivative for antimicrobial food packaging applications. Packaging Technology and Science, 19, 345-354.
180. Tan, M. L., Choong, P. F. M., Dass, C. R. (2010). Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides, 31, 184-193.
181. Taylor, T. M., Davidson, P. M., Bruce, B. D., Weiss, J. (2005). Liposomal nanocapsules in food science and agriculture. Critical Reviews in Food Science and Nutrition, 45, 587-605.
182. Gouin, S. (2004). Microencapsulation: Industrial appraisal of existing technologies and trends. Trends in Food Science and Technology, 15, 330-347.
183. Laridi, R., Kheadr, E. E., Benech, R. O., Vuillemard, J. C., Lacroix, C., Fliss, I. (2003). Liposome encapsulated nisin Z: Optimization, stability and release during milk fermentation. International Dairy Journal, 13, 325-336.
184. Benech, R. O., Kheadr, E. E., Laridi, R., Lacroix, C., Fliss, I. (2002). Inhibition of Listeria innocua in cheddar cheese by addition of nisin Z in liposomes or by in situ production in mixed culture. Applied and EnvironmentalMicrobiology, 68, 3683-3690.
185. Were, L. M., Bruce, B. D., Davidson, P. M., Weiss, J. (2003). Size, stability, and entrapment efficiency of phospholipid nanocapsules containing polypeptide antimicrobials. Journal of Agricultural and Food Chemistry, 51, 8073-8079.
186. da Silva Malheiros, P., Micheletto, Y. M. S., Silveira, N. P., Brandelli, A. (2010). Development and characterization of phosphatidylcholine nanovesicles containing the antimicrobial peptide nisin. Food Research International, 43, 1198-1203.
187. Taylor, T. M., Bruce, B. D., Weiss, J., Davidson, P. M. (2008). Listeria monocytogenes and Escherichia coli O157:H7 inhibition in vitro by liposome-encapsulated nisin and ethylene diaminetetraacetic acid. Journal of Food Safety, 28, 183-197.
188. Al-Nabulsi, A. A., Ran, J. H., Liu, Z. Q., Rodrigues-Vieira, E. T., Holley, R. A. (2006). Temperature-sensitive microcapsules containing lactoferrin and their action against Carnobacterium viridans on Bologna. Journal of Food Science, 71, M208-M214.
189. Fairman, R., âkerfeldt, K. S. (2005). Peptides as novel smart materials. Current Opinion in Structural Biology, 15, 453-463.
190. Rajagopal, K., Schneider, J. P. (2004). Self-assembling peptides and proteins for nanotechnological applications. Current Opinion in Structural Biology, 14, 480-486.
191. Gazit, E. (2007). Self-assembled peptide nanostructures: The design of molecular building blocks and their technological utilization. Chemical Society Reviews, 36, 1263-1269.
192. Hartmann, B. M., Kaar, W., Falconer, R. J., Zeng, B., Middelberg, A. P. J. (2008). Expression and purification of a nanostructure-forming peptide. Journal of Biotechnology, 135, 85-91.
193. Moers, A. P. H. A., Wolbert, E. J. H., de Wolf, F. A., Werten, M. W. T. (2010). Secreted production of self-assembling peptides in Pichia pastoris by fusion to an artificial highly hydrophilic protein. Journal of Biotechnology, 146, 66-73.
194. Riley, J. M., Aggeli, A., Koopmans, R. J., McPherson, M. J. (2009). Bioproduction and characterization of a pH responsive self-assembling peptide. Biotechnology and Bioengineering, 103, 241-251.
195. Chen, C., Pan, F., Zhang, S., Hu, J., Cao, M., Wang, J., Xu, H., Zhao, X., Lu, J. R. (2010). Antibacterial activities of short designer peptides: A link between propensity for nanostructuring and capacity for membrane destabilization. Biomacromolecules, 11, 402-411.
196. Eby, D. M., Farrington, K. E., Johnson, G. R. (2008). Synthesis of bioinorganic antimicrobial peptide nanoparticles with potential therapeutic properties. Biomacromolecules, 9, 2487-2494.
197. Liu, L., Xu, K., Wang, H., Jeremy Tan, P. K., Fan, W., Venkatraman, S. S., Li, L., Yang, Y. Y. (2009). Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nature Nanotechnology, 4, 457-463.
198. Wang, H., Xu, K., Liu, L., Tan, J. P. K., Chen, Y., Li, Y., Fan, W., Wei, Z., Sheng, J., Yang, Y. Y., Li, L. (2010). The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. Biomaterials, 31, 2874-2881.